COVID-19 Update

Pfizer and BioNTech Sign Supply Agreement with US Government for Vaccine Candidate

July 22, 2020

Pending approval of the Pfizer and BioNTech mRNA-based vaccine candidate against SARS-COV-2, the companies will supply the US government with an initial 100 million doses.

Drug Pricing Back in the Spotlight

July 21, 2020

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

AstraZeneca and IQVIA Partner on Potential COVID-19 Vaccine

July 21, 2020

The project will focus on providing a faster route to clinical studies for AstraZeneca’s potential COVID-19 vaccine, AZD1222.

UK Government Secures Early Access to Millions of COVID-19 Vaccine Doses

July 21, 2020

The UK government has secured early access to 90 million COVID-19 vaccine doses from the BioNTech/Pfizer alliance and Valneva.

mRNA Vaccine Produces Immune and T-cell Response

July 21, 2020

Preliminary data from a German Phase I/II trial shows Pfizer/BioNTech COVID-19 vaccine candidate produces immune response.

CanSino Vaccine Produces Immune Response

July 21, 2020

Study reports immune and T-cell response from CanSino COVID-19 vaccine candidate.

AstraZeneca/Oxford Vaccine Shows Antibody and T-cell Responses

July 20, 2020

A strong immune response by patients receiving two doses of AZD1222 vaccine suggests a possible dosing strategy for COVID-19 vaccine.

AstraZeneca Vaccine Shows Antibody and T-cell responses

July 20, 2020

Strong immune response by patients receiving two doses of vaccine suggests a possible treatment strategy.

Regulatory Authorities have Published a Report on COVID Vaccine Development

July 16, 2020

Global regulatory authorities have published a report describing the aligned positions on COVID-19 vaccine development, which were agreed upon by meeting participants of the second workshop on COVID-19 vaccine development.

Supplier Operations Status Report

July 15, 2020

Suppliers to the bio/pharma industry are sharing news about the business operations during the global COVID-19 pandemic. To view current information about the company’s business operations, click the company name.